137 related articles for article (PubMed ID: 17267240)
1. An overview of erdosteine antioxidant activity in experimental research.
Moretti M; Marchioni CF
Pharmacol Res; 2007 Apr; 55(4):249-54. PubMed ID: 17267240
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats.
Fadillioğlu E; Erdoğan H; Söğüt S; Kuku I
J Appl Toxicol; 2003; 23(1):71-4. PubMed ID: 12518339
[TBL] [Abstract][Full Text] [Related]
3. Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent.
Cazzola M; Page C; Rogliani P; Calzetta L; Matera MG
Drugs; 2020 Nov; 80(17):1799-1809. PubMed ID: 33025535
[TBL] [Abstract][Full Text] [Related]
4. Erdosteine improves oxidative damage in a rat model of renal ischemia-reperfusion injury.
Gurel A; Armutcu F; Cihan A; Numanoglu KV; Unalacak M
Eur Surg Res; 2004; 36(4):206-9. PubMed ID: 15263825
[TBL] [Abstract][Full Text] [Related]
5. Erdosteine modulates radiocontrast-induced hepatotoxicity in rat.
Yesildağ A; Ozden A; Yilmaz HR; Uz E; Ağackiran Y; Yesildağ M; Yilmaz N; Sirmali R; Vural H; Naziroğlu M
Cell Biochem Funct; 2009 Apr; 27(3):142-7. PubMed ID: 19277994
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of erdosteine on rotenone-induced oxidant injury in liver tissue.
Terzi A; Iraz M; Sahin S; Ilhan A; Idiz N; Fadillioglu E
Toxicol Ind Health; 2004 Sep; 20(6-10):141-7. PubMed ID: 15941011
[TBL] [Abstract][Full Text] [Related]
7. Effects of erdosteine treatment against doxorubicin-induced toxicity through erythrocyte and plasma oxidant/antioxidant status in rats.
Fadillioğlu E; Erdoğan H
Pharmacol Res; 2003 Apr; 47(4):317-22. PubMed ID: 12644389
[TBL] [Abstract][Full Text] [Related]
8. Effects of erdosteine on cyclosporin-A-induced nephrotoxicity.
Tutanc M; Arica V; Yılmaz N; Nacar A; Zararsiz I; Basarslan F; Tutanc OD; Nacar E
Hum Exp Toxicol; 2012 Jun; 31(6):565-73. PubMed ID: 21813577
[TBL] [Abstract][Full Text] [Related]
9. Erdosteine and ebselen as useful agents in intestinal ischemia/reperfusion injury.
Tunc T; Uysal B; Atabek C; Kesik V; Caliskan B; Oztas E; Ersoz N; Oter S; Guven A
J Surg Res; 2009 Aug; 155(2):210-6. PubMed ID: 19505699
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of erdosteine 900 versus 600 mg/day in reducing oxidative stress in patients with COPD exacerbations: Results of a double blind, placebo-controlled trial.
Dal Negro RW; Visconti M; Turco P
Pulm Pharmacol Ther; 2015 Aug; 33():47-51. PubMed ID: 26116425
[TBL] [Abstract][Full Text] [Related]
11. The effects of erdosteine on lung injury induced by the ischemia-reperfusion of the hind-limbs in rats.
Sirmali M; Uz E; Sirmali R; Kilbaş A; Yilmaz HR; Ağaçkiran Y; Altuntaş I; Delibaş N
J Surg Res; 2008 Apr; 145(2):303-7. PubMed ID: 17574582
[TBL] [Abstract][Full Text] [Related]
12. The protective effect of erdosteine against cyclosporine A-induced cardiotoxicity in rats.
Selcoki Y; Uz E; Bayrak R; Sahin S; Kaya A; Uz B; Karanfil A; Ozkara A; Akcay A
Toxicology; 2007 Sep; 239(1-2):53-9. PubMed ID: 17689165
[TBL] [Abstract][Full Text] [Related]
13. Protein oxidation and lipid peroxidation after renal ischemia-reperfusion injury: protective effects of erdosteine and N-acetylcysteine.
Erdogan H; Fadillioglu E; Yagmurca M; Uçar M; Irmak MK
Urol Res; 2006 Feb; 34(1):41-6. PubMed ID: 16429300
[TBL] [Abstract][Full Text] [Related]
14. Erdosteine ameliorates neurological outcome and oxidative stress due to ischemia/reperfusion injury in rabbit spinal cord.
Ege E; Ilhan A; Gurel A; Akyol O; Ozen S
Eur J Vasc Endovasc Surg; 2004 Oct; 28(4):379-86. PubMed ID: 15350559
[TBL] [Abstract][Full Text] [Related]
15. In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine.
Oktem F; Arslan MK; Ozguner F; Candir O; Yilmaz HR; Ciris M; Uz E
Toxicology; 2005 Nov; 215(3):227-33. PubMed ID: 16112787
[TBL] [Abstract][Full Text] [Related]
16. The protective effect of erdosteine on short-term global brain ischemia/reperfusion injury in rats.
Ozerol E; Bilgic S; Iraz M; Cigli A; Ilhan A; Akyol O
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):20-4. PubMed ID: 18930779
[TBL] [Abstract][Full Text] [Related]
17. Erdosteine prevents bleomycin-induced pulmonary fibrosis in rats.
Sogut S; Ozyurt H; Armutcu F; Kart L; Iraz M; Akyol O; Ozen S; Kaplan S; Temel I; Yildirim Z
Eur J Pharmacol; 2004 Jun; 494(2-3):213-20. PubMed ID: 15212977
[TBL] [Abstract][Full Text] [Related]
18. Protective agent, erdosteine, against cisplatin-induced hepatic oxidant injury in rats.
Koc A; Duru M; Ciralik H; Akcan R; Sogut S
Mol Cell Biochem; 2005 Oct; 278(1-2):79-84. PubMed ID: 16180092
[TBL] [Abstract][Full Text] [Related]
19. Effects of aminoguanidine and antioxidant erdosteine on bleomycin-induced lung fibrosis in rats.
Yildirim Z; Turkoz Y; Kotuk M; Armutcu F; Gurel A; Iraz M; Ozen S; Aydogdu I; Akyol O
Nitric Oxide; 2004 Sep; 11(2):156-65. PubMed ID: 15491848
[TBL] [Abstract][Full Text] [Related]
20. Protective role of caffeic acid phenethyl ester and erdosteine on activities of purine-catabolizing enzymes and level of nitric oxide in red blood cells of isoniazid-administered rats.
Yilmaz HR; Uz E; Gökalp O; Ozçelik N; Ciçek E; Ozer MK
Toxicol Ind Health; 2008 Sep; 24(8):519-24. PubMed ID: 19039079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]